IL6 and COVID-19: A retrospective analysis of patients from China suggested that raised markers of inflammation, particularly CRP and IL‐6, were poor prognostic markers in COVID‐19 [2, 5], and another study demonstrated the prognostic significance of elevated D‐dimers [6].